Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007

Journal of Medical Virology

Volumn 81, Issue 4, 2009, Pages 634-639

  Seme, Katja ^a   Vrhovac, Maja ^a   Močilnik, Tina ^a   Matičič, Mojca ^b   Lešničar, Gorazd ^c   Baklan, Zvonko ^b   Volkar, Jelka Meglič ^b   Rajter, Mojca ^b   Štepec, Srečko ^b   Lunar, Maja ^a   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c General Hospital Celje   (Slovenia)

Author keywords

Genotypes; HCV; Hepatitis C virus; Slovenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; DRUG USE; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SLOVENIA; VIRAL CONTAMINATION; VIRUS DETECTION; VIRUS TRANSMISSION; CLASSIFICATION; DISEASE TRANSMISSION; EPIDEMIC; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SUBSTANCE ABUSE; VIROLOGY;

HEPATITIS C VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; DISEASE OUTBREAKS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; SLOVENIA; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 62849096072     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21427     Document Type: Article

References (26)

1. Bouchardeau F, Cantaloube JF, Chevaliez S, Portal C, Razer A, Lefrère JJ, Pawlotsky JM, De Micco P, Laperche S. 2007. Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay. J Clin Microbiol 45:1140-1145.
2. Cenci M, Massi M, Alderisio M, De Soccio G, Recchia O. 2007. Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: An update and report of a new method of HCV genotyping. Anticancer Res 27:1219-1222.
3. Chevaliez S, Pawlotsky J-M. 2007. Hepatitis C virus: Virology, diagnosis, and management of antiviral therapy. World J Gastroenterol 13:2461-2466.
4. Chlabicz S, Flisiak R, Kowalczuk O, Grzeszczuk A, Pytel-Krolczuk B, Prokopowicz D, Chyczewski L. 2008. Changing HCV genotypes distribution in Poland-Relation to source and time of infection. J Clin Virol 42:156-159.
5. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, ComarM, Croce L, Tiribelli C, Campello C. 2002. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 68:352-356.
6. Echevarría JM, León P, Pozo F, Avellón A. 2006. Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a 9-year period (1996-2004). Enferm Infecc Microbiol Clin. 24:20-25.
7. Esteban JI, Sauleda S, Quer J. 2008. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48:148-162.
8. Hadziyannis SJ, Sette H, Jr., Morgan TR, Balan V, DiagoM, Marcellin P, Ramadori G, Bodenheimer H, Jr., Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM, PEGASYS International Study Group. 2004. Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140:346-355.
9. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. 2001. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol 20:41-47.
10. Maio G, d'Argenio P, Stroffolini T, Bozza A, Sacco L, Tosti ME, Intorcia M, Fossi E, d'Alessio G, Kondili LA, Rapicetta M, Mele A. 2000. Hepatitis C virus infection and alanine transaminase levels in the general population: A survey in a southern Italian town. J Hepatol 33:116-120.
11. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 358:958-965.
12. Matera G, Lamberti A, Quirino A, Foca D, Giancotti A, Barreca GS, Guadagnino V, Liberto MC. 2002. Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis 42:169-173.
13. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. 1995. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171:1607-1610.
14. Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C, Henquell C, Abergel A, Pawlotsky JM, Hezode C, Coudé M, Blanchi A, Alain S, Loustaud-Ratti V, Chevallier P, Trepo C, Gerolami V, Portal I, Halfon P, Bourliere M, Bogard M, Plouvier E, Laffont C, Agius G, Silvain C, Brodard V, ThiefinG, Buffet-Janvresse C, Riachi G, Grattard F, Bourlet T, Stoll-Keller F, Doffoel M, Izopet J, Barange K, Martinot-Peignoux M, Branger M, Rosenberg A, Sogni P, Chaix ML, Pol S, Thibault V, Opolon P, Charrois A, Serfaty L, Fouqueray B, Grange JD, Lefrère JJ, Lunel-Fabiani F. 2005. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat 12:405-413.
15. Roffi L, Ricci A, Ogliari C, Scalori A, Minola E, Colloredo G, Donada C, Ceriani R, Rinaldi G, Paris B, Fornaciari G, Morales R, Del Poggio P, Sangiovanni A, Buonocore M, Bellia V, Riboli P, Nava MC, Panizzuti F, Piperno A, Pozzi M, Pioltelli P, Mancia G. 1998. HCV genotypes in Northern Italy: A survey of 1368 histologically proven chronic hepatitis C patients. J Hepatol 29:701-706.
16. Roman F, Hawotte K, Struck D, Ternes AM, Servais JY, Arendt V, Hoffman P, Hemmer R, Staub T, Seguin-Devaux C, Schmit JC. 2008. Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World J Gastroenterol 14:1237-1243.
17. Ross RS, Viazov S, Renzing-Köhler K, Roggendorf M. 2000. Changes in the epidemiology of hepatitis C infection in Germany: Shift of predominance of hepatitis C subtypes. J Med Virol 60:122-125.
18. Sanchez-Quijano A, Abad MA, Torronteras R, Rey C, Pineda JA, Leal M, Macias J, Lissen E. 1997. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 27:25-29.
19. Seme K, Poljak M, Lešničar G, Brinovec V, Štepec S, Koren S. 1997a. Distribution of hepatitis C virus genotypes in Slovenia. Scan J Infect Dis 29:29-31.
20. Seme K, Poljak M, Žužek-Rešek S, Debeljak M, Dovč P, Koren S. 1997b. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 77:273-278.
21. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. 2005.
22. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
23. Trepo C, Pradat P. 1999. Hepatitis C virus infection in Western Europe. J Hepatol 31:80-83.
24. Trišler Z, Seme K, Poljak M, Čelan Lucu B, Sakoman S. 1999. Prevalence of hepatitis C and G virus infections among intravenous drug users in Slovenia and Croatia. Scan J Infect Dis 31:33-35.
25. Vince A, Iscić-Bes J, Zidovec Lepej S, Baca-Vrakela I, Bradarić N, Kurelac I, Vince DB. 2006. Distribution of hepatitis C virus genotypes in Croatia-a 10-year retrospective study of four geographic regions. Coll Antropol 30:139-143.
26. World Health Organization. 2002. Global distribution ofhepatitis A, B and C, 2001. Wkly Epidemiol Rec 77:45-47.